A Meta-Analysis and Investigation for the Source of Bias of Left Ventricular Volumes and Function by Three-Dimensional Echocardiography in Comparison With Magnetic Resonance Imaging




Determining accurate left ventricular (LV) function is clinically important. Three-dimensional echocardiography (3DE) achieves better estimation than 2-dimensional echocardiography. However, underestimation of LV volumes has often been reported without a systematic attempt to synthesize these data. This meta-analysis aimed to assess the bias of 3DE in evaluating LV volumes and ejection fraction (EF) and to investigate factors affecting that bias. Studies that compared LV volumes and/or EF between 3DE and magnetic resonance imaging were eligible. Meta-analysis of 95 studies including 3,055 subjects revealed significant underestimation of LV end-systolic volume (−4.7 ml, p <0.0001) and end-diastolic volume (−9.9 ml, p <0.0001), whereas measurement for EF revealed excellent accuracy (−0.13%, p = 0.41). Meta-regression analysis for factors of systematic bias in volumetry revealed that female gender and existence of cardiac disease were associated with more underestimation, whereas use of semiautomatic tracking and matrix-array transducers counteracted the underestimation. In conclusion, by meta-analysis synthesizing many small studies, we found underestimation of LV volumes and factors affecting the systematic bias by 3DE. These data provide a more detailed basis for analyzing and improving the accuracy of 3DE, an indispensable step toward further clinical application in LV assessment.


Accurate quantification of left ventricular (LV) volumes and function is gaining clinical importance. However, LV assessment by 2-dimensional echocardiography is limited by the foreshortened apical views and geometric assumptions. Magnetic resonance imaging (MRI) has been employed as the clinical gold standard, but is time and resource intensive and is sometimes contraindicated. Three-dimensional echocardiography (3DE) has shown better correlation than 2-dimensional echocardiography with MRI measurements in validation studies in vitro and in vivo. In clinical studies, however, underestimation of volumes and ejection fraction (EF) by 3DE has often been reported, creating major discrepancy in this field and hindering further clinical application of 3DE. There has been no systematic attempt to synthesize these data. Therefore, the aims of this study were to determine the existence and extent of systematic bias in LV volumes and EF measured by 3DE compared to MRI and to investigate patient characteristics and soft/hardware factors affecting the systematic bias.


Methods


We searched MEDLINE with the Medical Subject Heading function up to June 13, 2010. The key terms used for the literature search were “magnetic resonance imaging,” “left ventricle,” and “3-dimensional echocardiography” and relevant phrases. Articles that included these 3 key phrases were screened by title and abstract for relevance. The search was restricted to human studies published in English. References of relevant articles were also reviewed. Abstracts without subsequent full-text publications, reviews, comments, letters, and literature that were not original articles were excluded ( Figure 1 ).




Figure 1


Search strategy and included/excluded studies. Exact terms and words used for the search were (1) “MRI” ∨ “Magnetic Resonance” ∨ “MR” ∨ MeSH term “Magnetic Resonance Imaging”; (2) ([{(“three” ∨ “3”) ∧ (“dimensions” ∨ “dimensional”)} ∨ “3D” [∧ (“Echocardiogram” ∨ “Echocardiography” ∨ “Echocardiograph” ∨ “Echocardiographic”)] ∨ MeSH term “Echocardiography, 3-Dimensional”; (3) [“left” ∧ (“ventricle” ∨ “ventricular”)] ∨ “LV” ∨ (MeSH term “Heart Ventricle” ∧ “Left”). MeSH = Medical Subject Heading.


Studies were considered eligible if the article assessed the difference of LV end-systolic volume, LV end-diastolic volume, and/or LVEF between 3DE and MRI showing mean difference ± SD or if these data could be obtained from the original article. Independent reviewers (Y.J.S. and T.S.) retrieved full texts of the relevant articles to assess eligibility.


Mean difference ± SD of LV end-systolic volume, LV end-diastolic volume, and LVEF between 3DE and MRI were obtained from the text, tables, or graphs. If data were presented only graphically, crude numbers were obtained from the graph. If 1 article included different populations or methods of 3DE validated by MRI, results of each population and method were considered separate studies.


Meta-analysis was performed by random-effects model weighted by inverse variance to evaluate the systematic bias of LV end-systolic volume, LV end-diastolic volume, and LVEF between 3DE and MRI. Heterogeneity was assessed with Cochrane Q test by chi-square test and was quantified with the I 2 test.


Meta-regression analysis with inverse-variance weighted, random-intercept, fixed-slopes model was performed to investigate factors related to bias in LV end-systolic volume, LV end-diastolic volume, and LVEF. The dependent variable was the absolute difference between 3DE and MRI, and independent variables were determined a priori including number of patients in each study, mean patient age, percentage of women, percentage of patients with acquired or congenital cardiac disease, use of matrix-array transducer, use of semiautomatic contour tracking system compared to manual-only tracking, use of contrast agent, use of disk-summation method compared to apical-rotation method, number of manually tracked images, number of included subjects, and publication year. Independence of predictors was evaluated by a variance inflation factor. A maximal variance inflation factor <5 was used as a cutoff for independence.


Continuous values are presented as mean ± SD, and discrete variables are presented as percentages. Review Manager 5.0 (Nordic Cochrane Centre, Cochrane Collaboration, Copenhagen, Denmark) and SPSS 17.0 for Windows (SPSS, Inc., Chicago, Illinois) with Macro Syntax for meta-analysis and meta-regression analysis (D.B. Wilson, meta-analysis macros for SPSS, available at: http://mason.gmu.edu/∼dwilsonb/ma.html ) were used for analysis. A p value <0.05 was considered statistically significant.




Results


In total 292 titles were screened for relevance, of which 51 articles were considered eligible including 95 studies with a total of 3,055 subjects ( Figure 1 ). Most excluded studies were on mitral regurgitation from the search term “MR,” which was intended for MRI. Cross-reference check of relevant studies yielded 2 eligible articles. Table 1 lists characteristics of the included studies.



Table 1

Characteristics of included studies




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Study Number First Author Publication Year Number of Patients (men) Age (mean ± SD and/or range) Patient Characteristics Volumetric Method Matrix-Array Transducer Semiautomated Tracking Contrast Agents Miscellaneous Hardware Software
1 Apfel 1996 18 (8) 11.6 (0.75–42) PAH DS acoustic spatial locator GP 8-3D with model 77020AC
2 Iwase 1997 30 (26) 58 (22–83) 7 normal subjects, 23 with “various cardiac diseases” DS + CFM-800 with 2.5-MHz annular-array transducer
3 Altmann 1997 12 (8) 8.6 (0.5–22) single left ventricle DS acoustic spatial locator GP 8-3D with model 77020AC
4 Gopal 1997 30 (13) 56.6 ± 15.9 (15–87) 15 with IC, 5 with idiopathic or hypertensive CM, 5 with VHD, 2 with alcoholic CM, 1 with primary PAH, 2 with CHD DS acoustic spatial locator (Freepoint 3D § ) with model 77020AC
5 Buck 1997 23 (14) 63 ± 99 chronic stable LV aneurysms DS Sonolayer SSH-140A with 3.75-MHz transducer Echo-scan, TomTec ††
6 Nosir 1998 46 (36) 51 ± 17 (26–72) 15 normal subjects, 31 with IHD DS Sonolayer SSH-140A with 3.75-MHz transducer Echo-scan, TomTec ††
7 Mele 1998 20 (NR) NR 39 with IHD (32 after MI, 22 with aneurysm), 8 with VHD, 7 with CM DS 3.25-MHz annular array transducer of CFM 750 and 800 SuperVision Vingmed system
8 Danias 1998 41 (32) 39 ± 19 (24–77) 24 normal subjects, 17 with abnormal hearts, 14 with EF <55%, 13 with dilated left ventricle, 7 with regional LV systolic dysfunction DS (2 planes) Sonos 1500 system with 2.5-MHz transthoracic transducer Hewlett-Packard Series 735
9 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (4 planes) as above as above
10 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (6 planes) as above as above
11 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (8 planes) as above as above
12 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (10 planes) as above as above
13 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (12 planes) as above as above
14 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (16 planes) as above as above
15 Danias 1998 41 (32) 39 ± 19 (24–77) as above DS (20 planes) as above as above
16 Nosir 1999 15 (15) 52 ± 16.5 normal subjects DS A Sonolayer SSH-140A Echo-scan ††
17 Nosir 1999 15 (15) 52 ± 16.5 normal subjects DS B as above as above
18 Nosir 1999 25 (25) 52 ± 16.5 IC DS A as above as above
19 Nosir 1999 25 (25) 52 ± 16.5 IC DS B as above as above
20 Chuang 1999 8 (NR) NR NR NR Sonos 1500 or 2500 using 2.5-MHz phased-array probe custom scanner software
21 Chuang 1999 20 (16) 44 ± 16 (24–76) 7 with CAD and regional WMA, 2 with MV disease/LVD, 2 with impaired LV function, 1 with PDA/membranous VSD/DC, 1 with postpartum DC AR as above as above
22 Shiota 1999 19 (NR) NR 6 with aortic disease, 13 with CM DS 3D ultrasound system # with 2.5-MHz phased-array transducer software equipped with 3D system #
23 Qin 2000 32 (22) 54 ± 11 6 with right ventricular dysplasia, 9 with aortic regurgitation, 9 with MR, 4 with DC, 12 with IC AR (2 planes) NR 3D ultrasound system # with 2.5-MHz phased-array transducer 3D EchoTech ††
24 Qin 2000 32 (22) 54 ± 11 as above AR (4 planes) NR as above as above
25 Qin 2000 32 (22) 54 ± 11 as above AR (6 planes) NR as above as above
26 Qin 2000 32 (22) 54 ± 11 as above AR (9 planes) NR as above as above
27 Qin 2000 32 (22) 54 ± 11 as above DS NR as above as above
28 Nosir 2000 21 (15) 49 ± 16 (26–66) 5 healthy volunteers, 12 with ischemic segmental WMA, 4 with global hypokinesis from DC AR Sonolayer SSH-140A (3.75 MHz) Echo-scan, TomTec ††
29 Nosir 2000 21 (15) 49 ± 16 (26–66) as above AR Sonolayer SSH-140A (3.75 MHz) Echo-scan, TomTec ††
30 Nosir 2000 21 (15) 49 ± 16 (26–66) as above AR 16° Sonolayer SSH-140A (3.75 MHz) Echo-scan, TomTec ††
31 Hibberd 2000 25 (18) 23–76 12 healthy volunteers, 5 with IC with focal WMA, 8 with nonischemic DC NR Sonos 1500/2500 with 2.5-MHz phased-array transducer custom software
32 Kim 2001 10 (5) 25.2 ± 2.44 healthy volunteers AR (6 planes) + phased-array transducer (Vingmed System Five ) EchoPac-3D
33 Kim 2001 10 (5) 25.2 ± 2.44 healthy volunteers AR (6 planes) + with harmonic as above as above
34 Kim 2001 18 (NR) 59.9 ± 11.6 21 with IC, 1 with DC AR (6 planes) + as above as above
35 Kim 2001 18 (NR) 59.9 ± 11.6 21 with IC, 1 with DC AR (6 planes) + with harmonic as above as above
36 Poutanen 2001 30 (15) 10.6 ± 1.4 (8.4–13.2) healthy volunteers DS + GE Vingmed System Five ultrasound scanner (3.5 or 5 MHz)
37 Lee 2001 25 (17) 50.8 ± 15.4 “various cardiac disorders” AR (7 planes) + Volumetrics system # with a 2.5-MHz matrix-array transducer
38 Mannaerts 2003 27 (21) 50.2 ± 19.5 7 normal, 16 after MI (6 had apical aneurysm), 1 with HC, 2 with moderate aortic regurgitation, 1 with severe MR AR (2 planes) breath-hold ATL HDI 5000 Echo-scan 4.2, TomTec ††
39 Mannaerts 2003 27 (21) 50.2 ± 19.5 as above AR (2 planes) free-breath as above as above
40 Kühl 2004 24 (NR) NR 10 without apparent heart disease, 4 with DC, 10 with IC AR (8 planes) + + Sonos 7500 with X4 transducer CardioView RT
41 Jenkins 2004 50 (41) 64 ± 8 7 normal, 41 with regional WMA, 7 with global WMA due to hypertension AR (12 planes) + + Sonos 7500 with X4 transducer 4D analysis, Tomtec ††
42 Müller 2004 15 (12) 62 ± 8 6 with anterior MI, 4 with posterior MI AR (8 planes) Sequoia C 256 ⁎⁎ Tomtec ††
43 Müller 2004 15 (12) 62 ± 8 6 with anterior MI, 4 with posterior MI DS as above as above
44 Müller 2004 12 (8) 46 ± 19 normal subjects AR (8 planes) as above as above
45 Müller 2004 12 (8) 46 ± 19 normal subjects DS as above as above
46 Gutiérrez-Chico 2005 35 (28) 60.6 ± 16.6 (31–87) after MI AR (2 planes) + Sonos 7500 with X4 transducer 4D CardioView RT 1.0 Build 983
47 Gutiérrez-Chico 2005 35 (28) 60.6 ± 16.6 (31–87) after MI AR (4 planes) + as above as above
48 Gutiérrez-Chico 2005 35 (28) 60.6 ± 16.6 (31–87) after MI AR (8 planes) + as above as above
49 Bu 2005 19 (10) 10.6 ± 2.8 normal subjects AR (8 planes) + Sonos 7500 with X4 transducer (2–4 Hz) 4D CardioView RT 1.2
50 Corsi 2005 30 (19) 58 ± 19 6 normal volunteers, 11 with CAD, 9 with DC, 2 with VHD, 1 with aortic coarctation, 1 with right atrial mass + + Sonos 7500 with X4 transducer Matlab (MathWorks, Inc., Matick, Massachusetts)
51 Caiani 2005 46 (27) 53 ± 17 7 normal subjects, 9 with DC, 15 with CAD, 4 with LVH, 3 with myocarditis, 8 with VHD AR (4 planes) + + without contrast Sonos 7500 with X4 transducer (2–4 Hz) 3DQ–Qlab
52 Caiani 2005 14 (NR) NR NR AR (4 planes) + + + with contrast as above as above
53 Angelini 2005 10 (NR) 33 (6–63) PAH DS NR manual tracing not specified 3D EchoTech ††
54 Angelini 2005 10 (NR) 33 (6–63) PAH DS NR NR 3D-deformable model as above as above
55 Caiani 2005 20 (10) 58 ± 17 7 with CAD, 9 with DC, 2 with HC, 1 with PAH, 1 with normal left ventricle AR (4 planes) + + + continuous imaging Sonos 7500 with X4 transducer (2–4 Hz) 3DQ–Qlab
56 Caiani 2005 20 (10) 58 ± 17 as above AR (4 planes) + + + dual triggering as above as above
57 van den Bosch 2006 29 (19) 31 ± 9 (19–51) distorted LV geometry from congenital heart malformation AR (8 planes) + Sonos 7500 with X4 transducer 4D LV analysis 1.2 and EchoView 5.2 ††
58 Jacobs 2006 50 (27) 58 ± 19 24 with CAD, 18 with DC, 4 with VHD, 2 with aortic coarctation, 2 with right atrial mass AR + + Sonos 7500 with X4 transducer (2–4 Hz) 3DQ Advanced
59 Chan 2006 30 (23) 62 ± 9 after MI AR (12 planes) + + Sonos 7500 4D analysis, Tomtec ††
60 De Castro 2006 30 (30) NR 18 athletes, 12 sedentary men AR (8 planes) + NR Sonos 7500 with X4 transducer (2–4 Hz) 4D Cardio View RT, TomTec ††
61 Krenning 2006 17 (17) 52 (29–74) after MI AR (7 planes) + Vingmed Vivid 5 with 64-element array transducer (3 MHz) TomTec 4D LV analysis ††
62 Sugeng 2006 31 (17) 60 ± 15 9 with normal hearts, 14 with CAD, 7 with dilated ventricles, 1 with apical HC AR (6 planes) + + Sonos 7500 with X4 transducer in harmonic mode TomTec 4D LV analysis ††
63 Nikitin 2006 64 (51) 65 ± 12 10 normal subjects, 54 with cardiac disease AR (8 planes) + + Sonos 7500 with X4 transducer TomTec 4D LV analysis ††
64 Jenkins 2006 110 (94) 63 ± 10 LV dysfunction, 98 from regional WMA and 12 from global WMA AR (12 planes) + + off-line iE33 with 4× matrix-array transducer TomTec ††
65 Jenkins 2006 110 (94) 63 ± 10 as above automatic detection + + on-line as above Qlab
66 Qi 2007 58 (40) 59 (21–83) 14 normals, 23 with CAD, 7 with DC, 3 with ASD or VSD, 3 with VHD AR (8 planes) + iE33 with a 4× matrix-array transducer TomTec †† Echoview 5.2
67 Jenkins 2007 30 (22) 66 ± 7 after MI AR (12 planes) + + Matrix Sonos 7500 with X4 transducer TomTec †† 4D LV analysis
68 Jenkins 2007 30 (22) 66 ± 7 after MI AR (12 planes) + reconstruction as above as above
69 Soliman 2007 53 (28) 56 ± 12 9 with IC, 11 with noncompaction, 20 with HC, 13 with idiopathic DC AR (8 planes) + + multiplane interpolation Sonos 7500 with X4 transducer 4D LV analysis 1.2/EchoView 5.2 ††
70 Soliman 2007 41 (28) 56 ± 11 as above automated + + full-volume reconstruction as above TomTec 4D LV analysis 2.0 ††
71 Soliman 2007 41 (28) 56 ± 11 as above AR (2 planes) + + Qlab as above off-line QLAB 4.2, 3DQ Advanced
72 Krenning 2007 39 (34) 58 ± 15 (24–79) 28 after MI, 10 with CM, 1 with myocarditis AR (8 planes) + without contrast X4 transducer, Sonos 7500 (n = 18) or IE33 with X3-1 transducer (n = 21) TomTec EchoView 5.2 ††
73 Krenning 2007 39 (34) 58 ± 15 (24–79) 28 after MI, 10 with CM, 1 with myocarditis AR (8 planes) + + with contrast as above as above
74 Riehle 2008 12 (7) 15.9 (1–33) 5 with repaired ToF, 2 PS s/p valvotomy, 2 with aortic coarctation, 1 with midaortic stenosis, 1 with AS, 1 with anomalous left coronary artery AR (2 planes) + + iE33 with 1- to 3-MHz X3-1 matrix-array transducer 3DQ-LAB
75 Soriano 2008 27 (NR) 7 months functional single ventricle NR + Sonos 7500 with X4 transducer (2–4 Hz) 4D EchoView, TomTec ††
76 Lu 2008 20 (11) 10.6 ± 2.8 (6–18) 19 healthy volunteers, 1 with secundum ASD automated + + matrix-array transducer (X4, 2–4 MHz) QLAB-3DQ
77 Lu 2008 20 (11) 10.6 ± 2.8 (6–18) 19 healthy volunteers, 1 with secundum ASD AR (4 planes) + + as above 4D EchoView 5.4, TomTec ††
78 Lu 2008 20 (11) 10.6 ± 2.8 (6–18) 19 healthy volunteers, 1 with secundum ASD AR (8 planes) + + as above as above
79 Mor-Avi 2008 92 (69) 57 ± 16 “patients” AR + iE33 and an X3-1 matrix-array transducer QLAB-3DQ Advanced
80 Bicudo 2008 20 (13) 32 ± 14 HC NR + Sonos 7500 with X4 transducer Q-Lab 4.0 and 4.2.1
81 Pouleur 2008 83 (67) 54 ± 19 (7–85) 20 normal subjects, 20 with aortic valve disease, 10 with severe MR, 33 after MI NR + + Sonos 7500 or IE33 systems with matrix-array transducer Qlab
82 Soliman 2008 17 (12) 53 ± 15 7 normal subjects, 10 with IC, 7 with idiopathic DC AR + + iE33 with an X3-1 transducer QLAB-3DQ Advanced 6.0
83 Chukwu 2008 35 (22) 55.2 ± 15.4 normal subjects AR (2 planes) + + Sonos 7500 with X4 transducer 4D Echoview 5.3, TomTec ††
84 Chukwu 2008 35 (22) 55.2 ± 15.4 normal subjects AR (4 planes) + + as above as above
85 Chukwu 2008 35 (22) 55.2 ± 15.4 normal subjects AR (6 planes) + + as above as above
86 Chukwu 2008 35 (22) 55.2 ± 15.4 normal subjects AR (8 planes) + + as above as above
87 Chukwu 2008 35 (22) 55.2 ± 15.4 normal subjects 3D automated + + as above 4D LV analysis 2.0, TomTec ††
88 Chukwu 2008 35 (22) 65.8 ± 5.5 after MI AR (2 planes) + + as above as above
89 Chukwu 2008 35 (22) 65.8 ± 5.5 after MI AR (4 planes) + + as above as above
90 Chukwu 2008 35 (22) 65.8 ± 5.5 after MI AR (6 planes) + + as above as above
91 Chukwu 2008 35 (22) 65.8 ± 5.5 after MI AR (8 planes) + + as above as above
92 Chukwu 2008 35 (22) 65.8 ± 5.5 after MI 3D automated + + as above 4D LV analysis 2.0, TomTec ††
93 Jenkins 2009 50 (46) 63 ± 10 after MI AR (12 planes) + + without contrast Sonos 7500 with X4 transducer 4D LV analysis 2.0, TomTec ††
94 Jenkins 2009 50 (46) 63 ± 10 after MI AR (12 planes) + + + with contrast as above as above
95 Nesser 2009 43 (28) 59 ± 16 9 normal subjects, 17 with CAD (6 after MI), 10 with DC, 4 with myocarditis, 3 with VHD AR (2 planes) + + Artida 4D with matrix-array transducer (PST-25SX) 3D wall motion tracking software

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Dec 22, 2016 | Posted by in CARDIOLOGY | Comments Off on A Meta-Analysis and Investigation for the Source of Bias of Left Ventricular Volumes and Function by Three-Dimensional Echocardiography in Comparison With Magnetic Resonance Imaging

Full access? Get Clinical Tree

Get Clinical Tree app for offline access